Cargando…

UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells

Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) is a multi-domain E3 ubiquitin ligase which is involved in epigenetic regulation and plays an essential role in tumorigenesis. However, the role of UHRF2 in histone H3 acetylation has not yet been fully elucidated and few studies have reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ting, Zhao, Linglin, Zeng, Shengyuan, Bai, Lu, Chen, Junxia, Zhang, Zheng, Wang, Yalan, Duan, Changzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179198/
https://www.ncbi.nlm.nih.gov/pubmed/28004105
http://dx.doi.org/10.3892/ijmm.2016.2805
_version_ 1782485327915515904
author Zhang, Ting
Zhao, Linglin
Zeng, Shengyuan
Bai, Lu
Chen, Junxia
Zhang, Zheng
Wang, Yalan
Duan, Changzhu
author_facet Zhang, Ting
Zhao, Linglin
Zeng, Shengyuan
Bai, Lu
Chen, Junxia
Zhang, Zheng
Wang, Yalan
Duan, Changzhu
author_sort Zhang, Ting
collection PubMed
description Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) is a multi-domain E3 ubiquitin ligase which is involved in epigenetic regulation and plays an essential role in tumorigenesis. However, the role of UHRF2 in histone H3 acetylation has not yet been fully elucidated and few studies have reported its role in hepatocellular carcinoma (HCC). In this study, we examined the correlation between UHRF2 and acetylated H3 in HCC. Immunohistochemistry and western blot analysis demonstrated that the levels of histone H3 lysine 9 acetylation (H3K9ac) and histone H3 lysine 14 acetylation (H3K14ac) were higher in the HCC tissues and HepG2 HCC cells compared with the adjacent non-tumor tissues and L02 normal cells. The level of UHRF2 was higher in the HCC tissues compared with the adjacent non-tumor tissues, but its expression did not exhibit a significant difference between the HepG2 HCC cells and the L02 normal cells. In addition, when comparing the HCC tissues, a higher expression of UHRF2 correlated with a lower expression of H3K9ac in the HCC tissues. The overexpression of UHRF2 increased the expression of H3K9ac in L02 normal cells (P<0.01), but decreased the expression of H3K9ac in HepG2 cancer cells (P<0.05). Moreover, immunofluorescence staining and co-immunoprecipitation assay indicated that UHRF2 co-localized and interacted with H3K9ac in L02 and HepG2 cells and the plant homeodomain (PHD) finger domain was the key domain for UHRF2 directly binding to H3K9ac. Taken together, these results suggest that UHRF2 decreases the expression of H3K9ac in HepG2 HCC cells and interacts with it through the PHD domain.
format Online
Article
Text
id pubmed-5179198
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-51791982016-12-28 UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells Zhang, Ting Zhao, Linglin Zeng, Shengyuan Bai, Lu Chen, Junxia Zhang, Zheng Wang, Yalan Duan, Changzhu Int J Mol Med Articles Ubiquitin-like with PHD and ring finger domains 2 (UHRF2) is a multi-domain E3 ubiquitin ligase which is involved in epigenetic regulation and plays an essential role in tumorigenesis. However, the role of UHRF2 in histone H3 acetylation has not yet been fully elucidated and few studies have reported its role in hepatocellular carcinoma (HCC). In this study, we examined the correlation between UHRF2 and acetylated H3 in HCC. Immunohistochemistry and western blot analysis demonstrated that the levels of histone H3 lysine 9 acetylation (H3K9ac) and histone H3 lysine 14 acetylation (H3K14ac) were higher in the HCC tissues and HepG2 HCC cells compared with the adjacent non-tumor tissues and L02 normal cells. The level of UHRF2 was higher in the HCC tissues compared with the adjacent non-tumor tissues, but its expression did not exhibit a significant difference between the HepG2 HCC cells and the L02 normal cells. In addition, when comparing the HCC tissues, a higher expression of UHRF2 correlated with a lower expression of H3K9ac in the HCC tissues. The overexpression of UHRF2 increased the expression of H3K9ac in L02 normal cells (P<0.01), but decreased the expression of H3K9ac in HepG2 cancer cells (P<0.05). Moreover, immunofluorescence staining and co-immunoprecipitation assay indicated that UHRF2 co-localized and interacted with H3K9ac in L02 and HepG2 cells and the plant homeodomain (PHD) finger domain was the key domain for UHRF2 directly binding to H3K9ac. Taken together, these results suggest that UHRF2 decreases the expression of H3K9ac in HepG2 HCC cells and interacts with it through the PHD domain. D.A. Spandidos 2017-01 2016-11-17 /pmc/articles/PMC5179198/ /pubmed/28004105 http://dx.doi.org/10.3892/ijmm.2016.2805 Text en Copyright: © Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhang, Ting
Zhao, Linglin
Zeng, Shengyuan
Bai, Lu
Chen, Junxia
Zhang, Zheng
Wang, Yalan
Duan, Changzhu
UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells
title UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells
title_full UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells
title_fullStr UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells
title_full_unstemmed UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells
title_short UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells
title_sort uhrf2 decreases h3k9ac expression by interacting with it through the phd and sra/ydg domain in hepg2 hepatocellular carcinoma cells
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179198/
https://www.ncbi.nlm.nih.gov/pubmed/28004105
http://dx.doi.org/10.3892/ijmm.2016.2805
work_keys_str_mv AT zhangting uhrf2decreasesh3k9acexpressionbyinteractingwithitthroughthephdandsraydgdomaininhepg2hepatocellularcarcinomacells
AT zhaolinglin uhrf2decreasesh3k9acexpressionbyinteractingwithitthroughthephdandsraydgdomaininhepg2hepatocellularcarcinomacells
AT zengshengyuan uhrf2decreasesh3k9acexpressionbyinteractingwithitthroughthephdandsraydgdomaininhepg2hepatocellularcarcinomacells
AT bailu uhrf2decreasesh3k9acexpressionbyinteractingwithitthroughthephdandsraydgdomaininhepg2hepatocellularcarcinomacells
AT chenjunxia uhrf2decreasesh3k9acexpressionbyinteractingwithitthroughthephdandsraydgdomaininhepg2hepatocellularcarcinomacells
AT zhangzheng uhrf2decreasesh3k9acexpressionbyinteractingwithitthroughthephdandsraydgdomaininhepg2hepatocellularcarcinomacells
AT wangyalan uhrf2decreasesh3k9acexpressionbyinteractingwithitthroughthephdandsraydgdomaininhepg2hepatocellularcarcinomacells
AT duanchangzhu uhrf2decreasesh3k9acexpressionbyinteractingwithitthroughthephdandsraydgdomaininhepg2hepatocellularcarcinomacells